超声引导下人类胰岛移植:安全性、可行性与疗效分析
回顾性纳入22例受者(18例男性;平均年龄42.6±17.5岁)共35次手术,全程在超声引导下经右侧经肝途径行经皮肝门静脉穿刺置管并输注胰岛至门静脉主干,彩色多普勒与超声造影用于引导和监测并发症,输注后对穿刺通道行栓塞,若出血持续则行超声引导射频消融止血。技术成功率为100%(单次穿刺尝试),6次(17.1%)腹部出血经超声引导射频消融即刻止血,未发生门静脉血栓;透析(OR 32.0;95% CI 1.561-656.054;P=0.025)是与出血相关的显著因素。末次胰岛输注后1个月β评分显示原发移植物功能最佳8例(36.4%)、次佳13例(59.1%)、差1例(4.5%)。
要点
- 全程超声引导下经右侧经肝途径行经皮肝门静脉穿刺置管并输注胰岛至门静脉主干,技术成功率为100%(单次穿刺尝试)。
- 6次(17.1%)腹部出血经超声引导射频消融即刻止血,未发生门静脉血栓,并发症或自限或经无创治疗可控。
- 透析(OR 32.0;95% CI 1.561-656.054;P=0.025)是与出血相关的显著因素。
核心结论
- 全程超声引导下胰岛移植是治疗糖尿病安全、可行且有效的方法,并发症或自限或经无创治疗可控。
研究设计与样本
- 回顾性纳入22例受者(18例男性;平均年龄42.6±17.5岁)共35次手术,全程在超声引导下经右侧经肝途径行经皮肝门静脉穿刺置管并输注胰岛至门静脉主干,彩色多普勒与超声造影用于引导和监测并发症。
关键影像表现/征象
- 超声引导下经右侧经肝途径行经皮肝门静脉穿刺置管并输注胰岛至门静脉主干,技术成功率为100%(单次穿刺尝试)。
- 6次(17.1%)腹部出血经超声引导射频消融即刻止血,未发生门静脉血栓。
- 输注胰岛后对穿刺通道行栓塞,若出血持续则行超声引导射频消融止血。
诊断标准与关键数值
- 末次胰岛输注后1个月以β评分评估原发移植物功能:最佳8例(36.4%)、次佳13例(59.1%)、差1例(4.5%)。
- 透析与出血相关(OR 32.0;95% CI 1.561-656.054;P=0.025)。
临床应用与阅片要点
- 全程超声引导下经右侧经肝途径行经皮肝门静脉穿刺置管并输注胰岛至门静脉主干,彩色多普勒与超声造影用于引导和监测并发症。
- 输注后对穿刺通道行栓塞,若出血持续则行超声引导射频消融止血。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: We aimed to analyze the safety, feasibility, and efficacy of human islet transplantation (IT) using ultrasound (US) throughout the entire procedure.
MATERIALS AND METHODS: A total of 22 recipients (18 males; mean age 42.6 ± 17.5years) with 35 procedures were retrospective included. Under US guidance, percutaneous transhepatic portal catheterization was successfully performed through a right-sided transhepatic approach, and islets were infused into the main portal vein. Color Doppler and contrast-enhanced ultrasound were used to guide the procedure and monitor the complications. After infusion of the islet mass, the access track was embolized by embolic material. If hemorrhage persisted, US-guided radiofrequency ablation (RFA) was performed to stop bleeding. Factors that could affect the complication were analyzed. After transplantation, primary graft function was evaluated with a β-score 1month after the last islet infusion.
RESULTS: The technical success rates were 100% with a single puncture attempt. Six (17.1%) abdominal bleeding episodes were immediately stopped by US-guided RFA. No portal vein thrombosis were encountered. Dialysis (OR (Odd Ratio): 32.0; 95% CI: 1.561-656.054; and P = .025) was identified as a significant factor associated with bleeding. Primary graft function was optimal in eight patients (36.4%), suboptimal in 13 patients (59.1%), and poor in one patient (4.5%).
CONCLUSION: In conclusion, whole-procedure US-guided IT is a safe, feasible, and effective method for diabetes. Complications are either self-limiting or manageable with noninvasive treatment.
引用
- Yang, Zhuang, Duan, et al. Ultrasound-Guided Human Islet Transplantation: Safety, Feasibility, and Efficacy Analysis. Acad Radiol. 2023. PMID: 37280129. doi:10.1016/j.acra.2023.04.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。